Great Success for SOLOMAX: Final Evaluation Passed with Flying Colors!

Taken from

May 2025

We're excited and proud to share an important milestone we've achieved!

On April 29th and 30th, we hosted the final review meeting of the SOLOMAX project. (SOciaLNetwOrk of MedicAIEXperiences - F_260007/01-05/X51). Innovaway led the project as the lead partner this ambitious project, in collaboration with esteemed partners such as the University of Salerno, Ericsson's research center, the Minerva clinical facility, and Beyond IT.

The event was a key moment to present the final results to the representative from the Ministry of Enterprises and Made in Italy, responsible for evaluating the project funded by the Sustainable Growth Fund – "Life Sciences" sector. We were also pleased to host the Intesa Bank team for the administrative review.

During these two intense days, together with all our partners, we showcased the fruits of our labor: an innovative platform designed to support patients with cardiovascular diseases.Through networking tools, social sharing, blogtherapysymptomChecker and advanced features for diagnosis, prognosis, and medical history based on Artificial Intelligence (integrated into a specific app), SOLOMAX aims to bridge the gap between doctors and patients, supporting the latter throughout the complex journey from diagnosis to treatment.

The review, which included a thorough technical and administrative check of all activities carried out by the entire consortium, concluded with an extremely positive outcome! The high quality of the work and the full achievement of the goals we had set were recognized.

This result makes us proud and once again demonstrates Innovaway's ability to lead complex, high-innovation projects. Congratulations to everyone who contributed!


Share on
crossmenuchevron-down